Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2024 Dec 13:15:1447355.
doi: 10.3389/fneur.2024.1447355. eCollection 2024.

Copeptin as biomarker for acute ischemic stroke prognosis and revascularization treatment efficacy

Antonia Ioana Vasile  1   2 , Cristina Tiu  1   2 , Corin Badiu  2   3
Affiliations

Copeptin as biomarker for acute ischemic stroke prognosis and revascularization treatment efficacy

Antonia Ioana Vasile et al. Front Neurol. .

Abstract

Introduction: Pro-arginine vasopressin consists of three peptides: arginine-vasopressin, neurophysin II, and copeptin. AVP is released by the neurohypophysis in response to increased plasma osmolality, decreased blood volume and stress. Copeptin has the advantage of being stable ex vivo and easy to measure. New data show the importance of copeptin in ischemic stroke and its complications.

Methods: We present a literature review that highlights the importance of copeptin as a biological marker for stroke. We searched the Pubmed and Scopus databases for papers with the following keywords: "stroke AND copeptin." PRISMA criteria were used.

Results: We identified 332 papers that met the criteria. We excluded analyzed reviews, systematic reviews and meta-analyses. 31 articles resulted. The number of patients included in the analyzed studies varied between 18 and 4,302. Copeptin is a marker that associated with clinical stroke severity, infarct volume, short-term and long-term functionality and mortality and adds prognostic value to the previously used scales. It may reflect the effectiveness of revascularization therapy. Copeptin is a biomarker that can help predict post-stroke complications such as: cerebral edema and hemorrhagic transformation.

Discussion: Copeptin is a novel and promising biomarker for evaluating cerebrovascular diseases. Because it is considered a non-specific biomarker, it is not yet used routinely and it cannot replace the clinical examination. However, combined with other clinical or paraclinical parameters, it can increase the accuracy of the diagnosis.

Keywords: acute ischemic stroke; copeptin; stroke biomarkers; stroke prognosis; treatment efficiency in stroke patients.

PubMed Disclaimer

Conflict of interest statement

The authors declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest.

Figures

Figure 1
Figure 1
PRISMA flow diagram.
Figure 2
Figure 2
Benefits of copeptin use in ischemic stroke patients.
See this image and copyright information in PMC

Similar articles

See all similar articles

Cited by

References

    1. Hotter B, Hoffmann S, Ulm L, Meisel C, Fiebach JB, Meisel A. IL-6 plasma levels correlate with cerebral perfusion deficits and infarct sizes in stroke patients without associated infections. Front Neurol. (2019) 10:83. doi: 10.3389/fneur.2019.00083, PMID: - DOI - PMC - PubMed
    1. Johnston SC, Mendis S, Mathers CD. Global variation in stroke burden and mortality: estimates from monitoring, surveillance, and modelling. Lancet Neurol. (2009) 8:345–54. doi: 10.1016/S1474-4422(09)70023-7, PMID: - DOI - PubMed
    1. Koton S, Schneider AL, Rosamond WD, Shahar E, Sang Y, Gottesman RF, et al. . Stroke incidence and mortality trends in US communities, 1987 to 2011. JAMA. (2014) 312:259–68. doi: 10.1001/jama.2014.7692, PMID: - DOI - PubMed
    1. Tang W-Z, Wang X-B, Li H-T, Dong M, Ji X. Serum copeptin predicts severity and recurrent stroke in ischemic stroke patients. Neurotox Res. (2017) 32:420–5. doi: 10.1007/s12640-017-9754-5, PMID: - DOI - PubMed
    1. Blek N, Szwed P, Putowska P, Nowicka A, Drela WL, Gasecka A, et al. . The diagnostic and prognostic value of copeptin in patients with acute ischemic stroke and transient ischemic attack: a systematic review and meta-analysis. Cardiol J. (2022) 29:610–8. doi: 10.5603/CJ.a2022.0045, PMID: - DOI - PMC - PubMed

Publication types

LinkOut - more resources